Synbiotics Corporation EXHIBIT 11.1
------------
Computation of Earnings Per Share
- -----------------------------------------------------------------------------
Three Months Ended Six months Ended
June 30, June 30,
-------- --------
1997 1996 1997 1996
---------- ---------- ---------- ----------
Primary Earnings Per Share:
Net income per statement of operations $ 14,000 $1,519,000 $ 844,000 $3,169,000
========== ========== ========== ==========
Weighted average number of shares outstanding 7,505,000 6,028,000 7,499,000 5,968,000
========== ========== ========== ==========
Primary earnings per share $ .00 $ .25 $ .11 $ .53
========== ========== ========== ==========
Fully Diluted Earnings Per Share:
Net income per statement of operations $ 14,000 $1,519,000 $ 844,000 $3,169,000
========== ========== ========== ==========
Reconciliation of weighted average number of
shares per primary computation above, to
amount used for fully diluted computation:
Weighted average number of shares outstanding,
per primary computation 7,505,000 6,028,000 7,499,000 5,968,000
Add-effect of outstanding options (as determined
by the application of the treasury method) 19,000 38,000 13,000 26,000
---------- ---------- ---------- -----------
Weighted average number of shares, as adjusted 7,524,000 6,066,000 7,512,000 5,994,000
========== ========== ========== ===========
Fully diluted earnings per share $ .00 $ .25 $ .11 $ .53
========== ========== ========== ===========
-17-